Literature DB >> 567439

A comparative study of some combined treatment regimens in acute toxoplasmosis in mice.

E Thiermann, W Apt, A Atias, M Lorca, J Olguín.   

Abstract

The effectiveness of five treatment regimens was compared to mice during acute and late infection with Toxoplasma gondii. Parasitic cure rates, as judged by failure of brain tissue from surviving mice to produce infection when inoculated into clean mice, were as follows: pyrimethamine + sulfamethoxypyridazine, 92%; clindamycin + sulfamethoxypyridazine, 75%; spiramycin + sulfamethoxypyridazine, 16.7%; trimethoprim + sulfamethoxypryridazine alone, 0%. Pyrimethamine + sulfamethoxypyridazine was the most effective combination against acute toxoplasmosis in mice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567439     DOI: 10.4269/ajtmh.1978.27.747

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

Review 2.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

3.  Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.

Authors:  G A Filice; C Pomeroy
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  Therapy of ocular toxoplasmosis.

Authors:  A Rothova; H J Buitenhuis; C Meenken; G S Baarsma; T N Boen-Tan; P T de Jong; C M Schweitzer; Z Timmerman; J de Vries; M J Zaal
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

5.  Clindamycin in a murine model of toxoplasmic encephalitis.

Authors:  J M Hofflin; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; C K Kim; J M Foy; M J Linke; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 8.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.